National and Kapodistrian University of Athens
Ανάπτυξη πειραματικού εμβολίου εναντίον ενδοκυτταρικών παθογόνων
Abstract
dc:descriptionLeishmaniasis is a group of diseases caused by intracellular parasites of the genus Leishmania, displaying a spectrum of clinical manifestations from self-healing cutaneous to the life-threatening visceral form of the disease. The disease is prevalent in large areas of tropical, subtropical and the Mediterranean countries. Available chemotherapy is far from satisfactory, as existing drugs need multiple injections, have many side effects and practically show limited efficacy in some endemic areas due to the development of resistant parasites. Hence, there is an urgent need to develop an effective vaccine against leishmaniasis. Peptide and protein vaccines lack strong immunogenicity and thus require the use of an adjuvant. However, adjuvants may develop side effects and for that reason, microparticulate and nanoparticulate formulations are currently considered as ideal vaccine delivery systems. The aim of the present study was to investigate the ability of poly(lactic-co-glycolic) acid (PLGA) nanoparticles (NPs) to induce protection against experimental visceral leishmaniasis. Nanoformulations based on PLGA NPs were synthesized and encapsulated a crude mix of proteins from Leishmania infantum promastigotes (sLiAg) and MPLA, as adjuvant. PLGA NPs were surface-modified with a synthetic 8-peptide mimicking the TNFα docking region, in order to enhance dendritic cell targeting. Surface modified PLGA NPs were taken up more efficiently from dendritic cells compared to non-modified NPs. This is attributed to possible enhancement of dendritic cell targeting, as well as to the reduction of the absolute value of z potential. Incorporation of sLiAg and/or MPLA and surface modification with p8 induced the maturation and functional differentiation of dendritic cells, characterized by increased expression of surface molecules and intracellular production of cytokines, resulting in their enhanced ability of presenting parasitic antigens and activating in vitro T cells. Vaccination of BALB/c mice with PLGA-sLiAg-MPLA or p8-PLGA-sLiAg NPs induced significant reduction of parasite burden and development oflong-lasting immunity against L. infantum infection. Development of immunity was due to activation of T helper and cytotoxic T cell populations and simultaneous suppression of TH2 and regulatory T cell subpopulations. Based on the above results, the nanoformulations used are suggested as candidate vaccines against visceral leishmaniasis.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Margaroni, Maritsa
- Μαργαρώνη, Μαρίτσα
Subjects
dc:subject × 18- Ενδοκυτταρικά παθογόνα
- Λεϊσμανίαση
- Εμβόλια
- Νανοφορείς
- Πολυμερή γαλακτικού-γλυκολικού οξέος
- Intracellular pathogens
- Leishmaniasis
- Vaccines
- Nanoparticles
- PLGA nanoparticles
- Φυσικές Επιστήμες
- Βιολογία
- Επιστήμες Μηχανικού και Τεχνολογία
- Νανοτεχνολογία
- Natural Sciences
- Biological Sciences
- Engineering and Technology
- Nano-Technology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39056